跳至主要内容
临床试验/NCT04144959
NCT04144959已完成不适用

STRIDE: A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo Aspiration System

Penumbra Inc.17 个研究点 分布在 3 个国家目标入组 119 人开始时间: 2019年12月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Penumbra Inc.
入组人数
119
试验地点
17
主要终点
Target Limb Salvage Rate

研究概览

简要总结

The primary objective of this study is to collect safety and performance data on the Indigo Aspiration System in a patient population with lower extremity acute limb ischemia (LE ALI).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient age ≥ 18
  • Patient presents with acute (≤14 days) occlusion of lower limb artery(ies) (below inguinal ligament)
  • Patient with a Rutherford Category I, IIa or IIb score
  • Frontline treatment with Indigo Aspiration System
  • Informed consent is obtained from either patient or legally authorized representative (LAR)

排除标准

  • Life expectancy <1 year
  • Vessel size <2 mm
  • LE ALI secondary to dissections, vasculitis, and/or target vessel trauma
  • Amputation in the ipsilateral limb
  • Pregnancy or positive pregnancy test according to site specific standards of care (only required for women of child bearing potential, serum or urine acceptable)
  • Absolute contraindication to contrast administration
  • Patient is unwilling or unable to comply with protocol follow up schedule and/or based on the Investigator's judgment the patient is not a good study candidate
  • Currently participating in an investigational drug or device clinical trial that may confound the study endpoints. Patients in observational, natural history, and/or epidemiological studies not involving intervention are eligible.

结局指标

主要结局

Target Limb Salvage Rate

时间窗: 1-Month Post Procedure

Proportion of participants who did not have a major amputation (above the level of the tarsometatarsal joint)

次要结局

  • Technical Success(Immediate Post Procedure)
  • Modified Society for Vascular Surgery Runoff Score(Pre Procedure and immediately Post Procedure)
  • Improvement of Rutherford Classification(Up to discharge or 7 days, whichever occurred first)
  • Vessel Patency(1-Month Post-Procedure)
  • Target Limb Salvage Rate(12-Months Post Procedure)
  • Rates of Device Related Serious Adverse Events (SAEs)(Up until study completion, at approximately 12-Months)
  • Major Bleeding Peri-procedure(within 2 days of procedure)
  • Mortality(12-Months)

研究者

发起方
Penumbra Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (17)

Loading locations...

相似试验